This grant, offered by the National Cancer Institute (NCI) in collaboration with the National Institute of Allergy and Infectious Diseases (NIAID) and the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), is for supporting collaborative pilot projects. The primary purpose is to generate novel ideas and approaches aimed at reducing the incidence and severity of auto-inflammatory or autoimmune adverse events stemming from cancer immunotherapy. The program encourages the formation of multidisciplinary teams, specifically those combining current NCI grantees with either NIAID or NIAMS grantees. This collaborative effort leverages complementary expertise in cancer immunology, immunotherapy, immune tolerance, and autoimmunity to tackle critical challenges in cancer treatment side effects.
Opportunity ID: 292958
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PA-17-248 |
| Funding Opportunity Title: | Activities to Promote Research Collaborations on Immune-Related Adverse Events (APRC-irAEs) Associated with Cancer Immunotherapy (Admin Supp) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.396 — Cancer Biology Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Apr 03, 2017 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Jun 15, 2017 |
| Current Closing Date for Applications: | Jun 15, 2017 |
| Archive Date: | Jul 21, 2017 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) For profit organizations other than small businesses City or township governments Public and State controlled institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education Native American tribal governments (Federally recognized) County governments Independent school districts Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education State governments Special district governments Public housing authorities/Indian housing authorities Small businesses |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The overarching goal of this Funding Opportunity Announcement (FOA) is to support collaborative pilot projects to generate new ideas and approaches to reduce the incidence and/or severity of auto-inflammatory or autoimmune adverse events in the setting of cancer immunotherapy. In order to facilitate formation of multidisciplinary teams with expertise in mechanisms of cancer immunology/immunotherapy as well as immune tolerance and/or autoimmunity, teams that include (a) a current NCI grantee and a current NIAID grantee, or (b) a current NCI grantee and a current NIAMS grantee, are encouraged to propose collaborative pilot projects that utilize their complementary and synergistic expertise. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PA-17-248.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-D-ADMINSUPP-RESEARCH | Use for R00, R01, R35, R37 and U01 | PKG00231808 | May 15, 2017 | Jun 15, 2017 | View |
Package 1
Mandatory forms
292958 RR_SF424_2_0-2.0.pdf
292958 PHS398_CoverPageSupplement_3_0-3.0.pdf
292958 RR_OtherProjectInfo_1_3-1.3.pdf
292958 PerformanceSite_2_0-2.0.pdf
292958 RR_KeyPersonExpanded_2_0-2.0.pdf
292958 RR_Budget10_1_3-1.3.pdf
292958 PHS398_ResearchPlan_3_0-3.0.pdf
Optional forms
292958 RR_SubawardBudget10_30_1_3-1.3.pdf
292958 PHS_Inclusion_Enrollment_Report-1.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
